MINDIMMUNE

The nervous and immune systems are completely integrated in health and in disease. MindImmune is turning this insight into novel therapeutics targeting the immune system to treat brain disease... MindImmune has made a fundamental discovery that implicates the peripheral immune system in the pathology of Alzheimer's disease. We are developing a novel therapeutic antibody that blocks the immune attack on the brain to ‘nip Alzheimer's disease in the blood'... MindImmune's Board of Directors bring broad scientific, executive, and venture finance experience in neuroscience drug discovery and development to company governance.

Also known as: MindImmune Therapeutics, MindImmune Therapeutics, Inc.

Primary location: Kingston United States